论文部分内容阅读
目的:探讨联合必可酮、喘乐宁气雾剂对矽肺并发慢性阻塞性肺疾病(COPD)的疗效。方法:将128例矽肺并发COPD急性加重期患者随机分为治疗组和对照组,对照组采用常规治疗,治疗组在常规治疗基础上加用必可酮、喘乐宁气雾剂,疗程急性加重期后必可酮为6个月。结果:治疗组与对照组相比较,能显著改善患者的临床症状及肺功能。总有效率分别为92.3%和66.0%,两组比较差异有统计学意义(P<0.05)。结论:必可酮、喘乐宁气雾剂治疗矽肺并发COPD的疗效好。
Objective: To investigate the efficacy of combination of Bicone and Salbutamol Aerosol on patients with silicosis complicated with chronic obstructive pulmonary disease (COPD). Methods: A total of 128 patients with acute exacerbation of silicosis complicated with COPD were randomly divided into treatment group and control group. The control group was treated with conventional therapy. The treatment group was treated with the combination of Bicuone and Salbutamol Aerosol. After the period of ketoconazole for 6 months. Results: The treatment group compared with the control group, can significantly improve the clinical symptoms and lung function. The total effective rates were 92.3% and 66.0%, respectively, with significant difference between the two groups (P <0.05). Conclusion: It is effective to treat patients with silicosis complicated with COPD with bekoketone and salbutamol aerosol.